Other

Down payments and prepayments, non-current

Moderna Down payments and prepayments, non-current decreased by 3.0% to $97.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.5%, from $119.00M to $97.00M.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2022
Last reportedQ1 2026May 1, 2026
Metric ID: other_downpayments_and_prepayments_noncurrent

Historical Data

13 periods
 Q4 '22Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$303.00M$238.00M$342.00M$322.00M$321.00M$355.00M$139.00M$119.00M$111.00M$105.00M$100.00M$97.00M
QoQ Change-21.5%+43.7%-5.8%-0.3%+10.6%-60.8%-14.4%-6.7%-5.4%-4.8%-3.0%
YoY Change+5.9%+49.2%-59.4%-63.0%-65.4%-70.4%-28.1%-18.5%
Range$0.00$355.00M
Avg YoY Growth-31.2%
Median YoY Growth-43.7%
Current Streak6 quarters decline

Frequently Asked Questions

What is Moderna's down payments and prepayments, non-current?
Moderna (MRNA) reported down payments and prepayments, non-current of $97.00M in Q1 2026.
How has Moderna's down payments and prepayments, non-current changed year-over-year?
Moderna's down payments and prepayments, non-current decreased by 18.5% year-over-year, from $119.00M to $97.00M.